相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni et al.
LANCET NEUROLOGY (2020)
Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease
Tal Kozlovski et al.
FRONTIERS IN NEUROLOGY (2019)
New Era in disease modification in Parkinson's disease: Review of genetically targeted therapeutics
S. Pablo Sardi et al.
PARKINSONISM & RELATED DISORDERS (2019)
Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations
Gilad Yahalom et al.
PARKINSONISM & RELATED DISORDERS (2019)
GBA-Associated Parkinson's Disease and Other Synucleinopathies
Ziv Gan-Or et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study
Naveed Malek et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls
Steven A. Gunzler et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Progression in the LRRK2-Asssociated Parkinson Disease Population
Rachel Saunders-Pullman et al.
JAMA NEUROLOGY (2018)
Movement disorder society criteria for clinically established early Parkinson's disease
Daniela Berg et al.
MOVEMENT DISORDERS (2018)
Prevalence of pre-diagnostic symptoms did not differ between LRRK2-related, GBA-related and idiopathic patients with Parkinson's disease
Shu-Ying Liu et al.
PARKINSONISM & RELATED DISORDERS (2018)
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort
Kenneth Marek et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature
E. S. Fagan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies
Daryl J. Wile et al.
LANCET NEUROLOGY (2017)
Cognitive Impairment in Glucocerebrosidase (GBA)-Associated PD: Not Primarily Associated With Cerebrospinal Fluid Abeta and Tau Profiles
Stefanie Lerche et al.
MOVEMENT DISORDERS (2017)
GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease
Ignacio F. Mata et al.
MOVEMENT DISORDERS (2016)
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
Ganqiang Liu et al.
ANNALS OF NEUROLOGY (2016)
Survival and dementia in GBA-associated Parkinson's disease: The mutation matters
Roberto Cilia et al.
ANNALS OF NEUROLOGY (2016)
Neuropsychiatric characteristics of GBA-associated Parkinson disease
Matthew Swan et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Impulsive-compulsive behaviors inparkin-associated Parkinson disease
Francesca Morgante et al.
NEUROLOGY (2016)
High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews
Tamara Shiner et al.
JAMA NEUROLOGY (2016)
Cognitive Profile of LRRK2-Related Parkinson's Disease
Sindhu Srivatsal et al.
MOVEMENT DISORDERS (2015)
Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene
Johanne Hatteland Somme et al.
PARKINSONISM & RELATED DISORDERS (2015)
LRRK2 mutations in Parkinson disease; a sex effect or lack thereof? A meta-analysis
Ziv Gan-Or et al.
PARKINSONISM & RELATED DISORDERS (2015)
Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease
Roy N. Alcalay et al.
PARKINSONISM & RELATED DISORDERS (2015)
Evolution of Prodromal Clinical Markers of Parkinson Disease in a GBA Mutation-Positive Cohort
Michelle Beavan et al.
JAMA NEUROLOGY (2015)
Novel recruitment strategy to enrich for LRRK2 mutation carriers
Tatiana Foroud et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2015)
GBA-Associated Parkinson's Disease: Reduced Survival and More Rapid Progression in a Prospective Longitudinal Study
Kathrin Brockmann et al.
MOVEMENT DISORDERS (2015)
GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder
Ziv Gan-Or et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction
Edward I. Ginns et al.
MOLECULAR GENETICS AND METABOLISM (2014)
Parkinson Disease Phenotype in Ashkenazi Jews With and Without LRRK2 G2019S Mutations
Roy N. Alcalay et al.
MOVEMENT DISORDERS (2013)
Genetics of Parkinson's disease – state of the art, 2013
Vincenzo Bonifati
PARKINSONISM & RELATED DISORDERS (2013)
Clinical and Biochemical Differences in Patients Having Parkinson Disease With vs Without GBA Mutations
Lama M. Chahine et al.
JAMA NEUROLOGY (2013)
Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease
Samia Ben Sassi et al.
PARKINSONISM & RELATED DISORDERS (2012)
GBA-associated PD presents with nonmotor characteristics
K. Brockmann et al.
NEUROLOGY (2011)
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek et al.
PROGRESS IN NEUROBIOLOGY (2011)
Frequency of Known Mutations in Early-Onset Parkinson Disease
Roy N. Alcalay et al.
ARCHIVES OF NEUROLOGY (2010)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease
Z. Gan-Or et al.
NEUROGENETICS (2010)
LRRK2 G2019S mutation in Parkinson's disease: A neuropsychological and neuropsychiatric study in a large Algerian cohort
Soreya Belarbi et al.
PARKINSONISM & RELATED DISORDERS (2010)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation
Ioannis U. Isaias et al.
MOVEMENT DISORDERS (2006)
LRRK2 G2019S mutation and Parkinson's disease: A clinical, neuropsychological and neuropsychiatric study in a large Italian sample
Stefano Goldwurm et al.
PARKINSONISM & RELATED DISORDERS (2006)
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation
JR Adams et al.
BRAIN (2005)
Clinical traits of LRRK2-associated Parkinson's disease in Ireland: A link between familial and idiopathic PD
D Gosal et al.
PARKINSONISM & RELATED DISORDERS (2005)
分享论文
